The impact of DXA findings on general practitioners’ decision regarding first-line oral bisphosphonates in postmenopausal osteoporosis—data from French General Practice (the IMOGENE study)
Our study suggests insufficient awareness of national recommendations for PMO treatment in French general practice, highlighting the need for stronger GP education.
Authors
- P. Samama
- Teresa Garot
- Leila Chelbani
- Bernard Cortet
Institutions
- Université d'Orléans (FR)
- Université de Lille (FR)
- Lille’s Cardiology Hospital (FR)
- DuPont (France) (FR)
- Centre hospitalier universitaire d'Orléans (FR)
- Laboratoire d'étude de l'apprentissage et du développement (FR)
Publication Details
- Journal
- Archives of Osteoporosis
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1007/s11657-026-01663-3
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00